AKT1 and prostate carcinoma: Numerous studies have demonstrated the critical role of the PI3K/AKT signaling pathway in prostate cancer, including inducing apoptosis [40], causing cell cycle arrest [41], and regulating EMT progression [42] to inhibit tumor cell growth, migration, and invasion [43].